Jessica M. Haverkamp, Ph.D. - Publications

Affiliations: 
2011 Immunology University of Iowa, Iowa City, IA 
Area:
Immunology

5 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2022 Calvert RD, Fleet JC, Fournier PGJ, Juarez P, Burcham GN, Haverkamp JM, Guise TA, Ratliff TL, Elzey BD. Monocytic Myeloid-Derived Suppressor Cells from Tumor Tissue Are a Differentiated Cell with Limited Fate Plasticity. Immunohorizons. 6: 790-806. PMID 36480485 DOI: 10.4049/immunohorizons.2200079  0.373
2011 Svensson RU, Haverkamp JM, Thedens DR, Cohen MB, Ratliff TL, Henry MD. Slow disease progression in a C57BL/6 pten-deficient mouse model of prostate cancer. The American Journal of Pathology. 179: 502-12. PMID 21703427 DOI: 10.1016/J.Ajpath.2011.03.014  0.733
2011 Haverkamp JM, Charbonneau B, Crist SA, Meyerholz DK, Cohen MB, Snyder PW, Svensson RU, Henry MD, Wang HH, Ratliff TL. An inducible model of abacterial prostatitis induces antigen specific inflammatory and proliferative changes in the murine prostate. The Prostate. 71: 1139-50. PMID 21656824 DOI: 10.1002/Pros.21327  0.584
2011 Haverkamp JM, Crist SA, Elzey BD, Cimen C, Ratliff TL. In vivo suppressive function of myeloid-derived suppressor cells is limited to the inflammatory site. European Journal of Immunology. 41: 749-59. PMID 21287554 DOI: 10.1002/Eji.201041069  0.606
2008 Haverkamp J, Charbonneau B, Ratliff TL. Prostate inflammation and its potential impact on prostate cancer: a current review. Journal of Cellular Biochemistry. 103: 1344-53. PMID 17955503 DOI: 10.1002/Jcb.21536  0.586
Show low-probability matches.